Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile

Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME6523D
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondary antibodies, immunoassay kits and reagents, cell and tissue imaging tools, cellular and biochemical assays, proteins and peptides, proteomics tools, agonists, activators, antagonists and inhibitors, lysates, and multiplex miRNA assay. Abcam's products are used by life science researchers to identify proteins for life sciences and veterinary sciences. The company distributes its products in the Americas, Europe, Asia-Pacific and other countries. Abcam is headquartered in Cambridge, Cambridgeshire, the UK.

Abcam Plc (ABC)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Abcam Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Abcam Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Abcam Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Abcam Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Abcam Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Abcam Plc, Medical Equipment, Deal Details 10

Venture Financing 10

Firefly BioWorks Raises USD0.8 Million in Venture Financing 10

Partnerships 11

Abcam Enters Into Licensing Agreement With Columbia University For Fluorescent False Neurotransmitters 11

Abcam and Molecular Devices Enter into Partnership 12

TTP LabTech and Abcam Enter into Partnership 13

Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 14

Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 15

Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 16

Abcam Enters into Licensing Agreement with Roche 17

Acquisition 18

Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 18

Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For USD 155 Million 19

Abcam Plc-Key Competitors 20

Abcam Plc-Key Employees 21

Abcam Plc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 24

Financial Announcements 24

Sep 10, 2018: Abcam: Preliminary results 2018 24

Mar 05, 2018: Abcam: Interim results for the six months ended 31 December 2017 26

Sep 11, 2017: Abcam: Double-digit earnings growth enabling investment for sustained future growth 27

Corporate Communications 28

Oct 30, 2018: Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development 28

Jun 18, 2018: Abcam Appoints Peter Allen As Chairman 29

Nov 15, 2017: ABCAM: Result of AGM and Directorate Change 30

Oct 11, 2017: Abcam: Directorate Change-Chairman 31

Product News 32

Feb 07, 2018: New CatchPoint SimpleStep ELISA fluorescent 90-minute assay 32

Oct 23, 2017: New multiplex assay technology for RNA and protein quantitation 33

Other Significant Developments 34

Apr 26, 2018: Abcam And Shuwen Biotech Sign Strategic MoU To Establish Global Alliance For Companion Diagnostic (CDx) Kit Development 34

Jul 27, 2017: Abcam: Pre-Close Period Update 35

May 18, 2017: Abcam Makes Final Performance-Based AxioMx Milestone Payment 36

Mar 06, 2017: Abcam: Interim Results delivering double digit sales growth 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Figures

Abcam Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Abcam Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Abcam Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Abcam Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Abcam Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Abcam Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Abcam Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Abcam Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

List of Tables

Abcam Plc, Medical Equipment, Key Facts, 2018 2

Abcam Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Abcam Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Abcam Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Abcam Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Abcam Plc, Deals By Market, 2012 to YTD 2018 8

Abcam Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Firefly BioWorks Raises USD0.8 Million in Venture Financing 10

Abcam Enters Into Licensing Agreement With Columbia University For Fluorescent False Neurotransmitters 11

Abcam and Molecular Devices Enter into Partnership 12

TTP LabTech and Abcam Enter into Partnership 13

Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 14

Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 15

Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 16

Abcam Enters into Licensing Agreement with Roche 17

Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 18

Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For USD 155 Million 19

Abcam Plc, Key Competitors 20

Abcam Plc, Key Employees 21

Abcam Plc, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Abcam Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17848
Site License
USD 500 INR 35695
Corporate User License
USD 750 INR 53543

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com